PHAXIAM Therapeutics S.A. OverviewPHAXIAM Therapeutics S.A. Other Income Expense Net
Other Income/Expense Net for PHXM.
Quarterly Other Income/Expense
$228000.00
↑ 467.74% YoY
As of Dec 31, 2023
Annual Other Income/Expense (TTM)
$277000.00
↓ 68.74% YoY
Trailing 12 months ending Dec 31, 2023